Erin Polak

Erin Polak is the Senior Director for Government Affairs and Alliance Development at GRAIL. GRAIL is leveraging deep genetic sequencing and machine learning to bring an innovative multi-cancer early detection blood test to patients that ​seeks to save lives by extending the benefits of early detection to cancers that lack screening today.

Erin joined GRAIL in December 2019. In her role, she is responsible for federal advocacy and national alliance development. Prior to joining GRAIL, she spent thirteen years in the biopharmaceutical industry, including eleven years at Merck & Co., Inc. where she led the federal advocacy strategy for Merck’s oncology portfolio, including the launch of KEYTRUDA.

Erin received her B.A. from the University of Virginia. She enjoys traveling, spending time with her family and friends, and outdoor adventures.